Clinical Performance and Wear Resistance of Highly Translucent Nano Zirconia Reinforced Glass Ionomer Filling Versus Conventional Resin Composite Restorations in Patients With Proximal Carious Teeth. (A One-year Randomized Clinical Trial).

May 29, 2022 updated by: Weaam Mohamed Abdelfatah Abdelfatah Ammar, Cairo University
This randomized clinical study aims to evaluate the clinical performance and occlusal wear resistance of nano-zirconia reinforced glass ionomer restorations in comparison to Nano-hybrid resin composite in proximal cavities.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Statement of the problem:

The glass ionomer restorations have a wide use in dental community. Proximal restoration is a challenge, due to the high forces present in this area that require more high fracture resistance restoration material which is not obtained in the most of the versions of glass ionomer restorations that are available in dental market.(Safy, 2019)

Rationale for choice of intervention:

Zirconomer improved, is a nano zirconia reinforced glass ionomer, which has improved the mechanical, esthetic and handling properties than its previous successor, zirconomer. Zirconomer is commercialized as a white amalgam as it features mechanical properties similar to amalgam restorations. In this generation also, translucency is improved to be similar to the tooth structure.(Shetty et al, 2017) As Zirconomer improved is reinforced material, it is expected that has high wear resistance than the conventional glass ionomer restorations. (Hesse et al., 2018)

Study Type

Interventional

Enrollment (Anticipated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age group 18-55
  • Presence of occluding tooth.
  • Good oral hygiene

Exclusion Criteria:

  • Poor periodontal status
  • Adverse medical history.
  • Potential behavioral problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Zirconomer improved
a nano zirconia reinforced glass ionomer, which has improved the mechanical, esthetic and handling properties than its previous successor.
Zirconomer improved, is a nano zirconia reinforced glass ionomer, which has improved the mechanical, esthetic and handling properties than its previous successor.
Active Comparator: Nano hybird resin composite
Resin composite (RC) is the gold standard esthetic restoration in proximal cavities due to their high aesthetic properties, increased mechanical durability and enhanced adhesion to tooth structure.
Zirconomer improved, is a nano zirconia reinforced glass ionomer, which has improved the mechanical, esthetic and handling properties than its previous successor.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
Postoperative Hypersensitivity Secondary caries
Change from the baseline at 6 months and at 12 months.
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
Secondary caries and measured by Modified United States Public Health Service Criteria (USPHS)
Change from the baseline at 6 months and at 12 months.
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
Gross fracture and measured by Modified United States Public Health Service Criteria (USPHS)
Change from the baseline at 6 months and at 12 months.
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
Color match and measured by Modified United States Public Health Service Criteria (USPHS)
Change from the baseline at 6 months and at 12 months.
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
Cavo-surface marginal discoloration and measured by Modified United States Public Health Service Criteria (USPHS)
Change from the baseline at 6 months and at 12 months.
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
Marginal integrity and measured by Modified United States Public Health Service Criteria (USPHS)
Change from the baseline at 6 months and at 12 months.
Clinical performance
Time Frame: Change from the baseline at 6 months and at 12 months.
Proximal contact and measured by Modified United States Public Health Service Criteria (USPHS)
Change from the baseline at 6 months and at 12 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wear resistance evaluation
Time Frame: Change from the baseline at 6 months and at 12 months.
"Wear measurements Measured by using WSxM software.
Change from the baseline at 6 months and at 12 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ahmed El-Hoshy, Professor, Cairo university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2022

Primary Completion (Anticipated)

June 1, 2022

Study Completion (Anticipated)

February 1, 2023

Study Registration Dates

First Submitted

February 2, 2022

First Submitted That Met QC Criteria

May 29, 2022

First Posted (Actual)

June 2, 2022

Study Record Updates

Last Update Posted (Actual)

June 2, 2022

Last Update Submitted That Met QC Criteria

May 29, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • Zirconomer Improved

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries

Clinical Trials on Zirconomer improved

Subscribe